Jefferies LLC top stories-
Mizuho picks up four HY bankers
A clutch of traders and sales bankers are joining Mizuho International within fixed income, focusing on high yield, investment grade, securitization and SSA.
-
Former CLSA CEO Slone joins Jefferies
CLSA’s former chief executive Jonathan Slone has joined Jefferies Group as chairman of Asia, adding to the growing exodus of staff from the Citic Securities-backed bank to the US firm.
-
Jefferies enters the banking mainstream
By offering top level relationships and niche sector coverage, Jefferies has become a pillar of stability in corporate finance, writes David Rothnie. Now it is playing a more active role in public company takeovers.
-
Jefferies hires Wood for equity strategy
Jefferies has hired CLSA's Christopher Wood as global head of equity strategy.
-
Metro Bank cheers Brexit-weary UK with £375m block
Metro Bank completed its long awaited equity capital raise on Thursday night, providing a rare bit of good news to UK bankers and investors despondent over a tortuous Brexit process.
Latest market news
-
Premier Oil prepares $500m capital increase
Premier Oil has become the first company to announce a major ECM transaction in 2020, a £385m ($500m) capital increase to repay debt and finance the acquisition of two UK North Sea oilfields from BP.
-
Chinese biotech firm I-Mab launches $111m US listing
I-Mab, a China-based biopharmaceutical company, has kicked off the roadshow for its up to $111.1m Nasdaq IPO, more than two months after filing draft documents with the US regulator.
-
Boohoo Group co-founders sell down £142m of shares
The co-founders of Boohoo Group, the UK online fashion retailer, have offloaded £142.5m of stock.
-
Alphamab kicks open $234m Hong Kong listing
Alphamab Oncology, a Chinese biopharmaceutical firm, has launched a roadshow for an up to HK$1.83bn ($233.8m) listing, according to a source close to the deal.
-
Alphamab pre-markets Hong Kong IPO, eyes $1bn valuation
Alphamab Oncology, a Chinese biopharmaceutical company, kicked off pre-deal investor education for a potential $250m IPO on Monday after gaining approval to list from the Hong Kong Stock Exchange.
Jefferies LLC In The Key League Tables
| Asset | Rank | STLY | Amount $bn | No of issues | Share % | STLY Share % |
|---|---|---|---|---|---|---|
|
|
||||||
| Global Syndicated Loan Volume | 5 | 0.21 | 1 | 9.92% | ||
| Global IB Revenue | 16 | 14 | 0.22 | 249 | 1.11% | 1.29% |
| Global M&A Revenue | 11 | 14 | 0.15 | 57 | 2.15% | 1.59% |
| Equity Capital Markets Revenue | 21 | 13 | 0.04 | 21 | 1.07% | 1.65% |
| EMEA M&A Revenue | 16 | 33 | 0.03 | 12 | 1.45% | 0.47% |
| All Investment Banking Revenue Americas | 13 | 11 | 0.17 | 210 | 1.61% | 1.97% |
| Americas M&A Revenue | 11 | 12 | 0.12 | 41 | 2.78% | 2.29% |
| Equity Capital Markets Revenue - Americas | 18 | 11 | 0.02 | 12 | 1.31% | 2.49% |
| All Corporate Bonds | 19 | 54 | 1.57 | 3 | 2.00% | 0.34% |
| Dollar Denominated DCM | 22 | 25 | 1.57 | 4 | 1.33% | 0.63% |
| Bookrunners of Dollar Denominated HY Bonds | 1 | 2 | 1.57 | 3 | 14.07% | 13.70% |
Want full access to GlobalCapital?
If you are new to GlobalCapital or you already subscribe to some of our channels you can still easily extend your access.
Take a trial to the entire site or subscribe online to see all our capital markets news, opinion and data sets.
Don't miss out!
Free trial
Latest Issue
Read the magazine on your mobile device
Bank Profiles
Latest news by market and league table performance
Bond Comments
-
UniCredit €1.25bn 1.2% Jan 26 6NC5, €750m 1.8% Jan 30 bail-in senior
-
Banca Monte dei Paschi di Siena €400m 8% 10NC5 tier two
-
IDA GBP1.5bn 0.75% Dec 24
-
Italy EUR7bn 2.45% Sep 50
-
Belgium EUR6bn 0.1% Jun 30
-
CEB EUR1bn 0.05% Jan 30
-
KfW USD5bn 1.625% Feb 23
-
Cyprus EUR1bn 0.625% Jan 30, EUR750m 1.25% Jan 40
-
EFSF EUR3bn 0.7% Jan 50
-
Spain EUR10bn 0.5% Apr 30
-
UBI Banca EUR400m 5.875% PNC Jun 25 AT1
-
Banco BPM EUR400m 6.125% PNC5 AT1
-
Veon USD300m tap of USD 4% Apr 25
-
TSKB USD400m 6% Jan 20
-
First Abu Dhabi Bank USD500m 2.526% Jan 25
All International Bonds
| Rank | Lead Manager | Amount $bn | No of issues | Share % |
|---|---|---|---|---|
| 1 | Citi | 29.61 | 88 | 8.60% |
| 2 | JPMorgan | 23.76 | 85 | 6.90% |
| 3 | Barclays | 20.64 | 81 | 5.99% |
| 4 | BofA Securities | 19.82 | 71 | 5.76% |
| 5 | BNP Paribas | 16.27 | 62 | 4.73% |
Bookrunners of All Syndicated Loans EMEA
| Rank | Lead Manager | Amount $bn | No of issues | Share % |
|---|---|---|---|---|
| 1 | BNP Paribas | 60.84 | 264 | 7.99% |
| 2 | Credit Agricole CIB | 47.68 | 243 | 6.26% |
| 3 | JPMorgan | 35.73 | 111 | 4.69% |
| 4 | SG Corporate & Investment Banking | 34.28 | 171 | 4.50% |
| 5 | UniCredit | 33.71 | 188 | 4.43% |
Bookrunners of all EMEA ECM Issuance
| Rank | Lead Manager | Amount $bn | No of issues | Share % |
|---|---|---|---|---|
| 1 | Barclays | 0.75 | 7 | 12.00% |
| 2 | Morgan Stanley | 0.70 | 5 | 11.15% |
| 3 | JPMorgan | 0.58 | 5 | 9.31% |
| 4 | Citi | 0.48 | 4 | 7.75% |
| 5 | Goldman Sachs | 0.43 | 3 | 6.92% |
